Novogen, a subsidiary of Grimaud Group, announced that it has acquired a hatchery at Gare d'Uzel in Brittany, France, that will house grandparent stock production -- to be distributed worldwide -- and parent stock, which will be distributed throughout the Europe/Middle East/Africa region and Asia.
According to the announcement, this new production facility supplements Novogen's current installations in the U.S. and Brazil, which allows it to cover North and South America.
“This investment represents a major milestone for Novogen's 2030 strategy. It immediately increases production capacity to nearly 4 million layers, with room for more. This is excellent news that allows us to confidently develop our activities,” Novogen managing director Mickaël Le Helloco explained.
Because it is in close proximity to its Plédran headquarters, this hatchery will allow Novogen to fulfil its excellence strategy for the quality of delivered products using state-of-the-art equipment, the company said.
Novogen has initiated a renovation plan to ensure that the hatchery is put into operation in early summer of 2020.
Established in 2008, Novogen is present in more than 50 countries and has subsidiaries located in the U.S. and Brazil.
Groupe Grimaud is a world leader in multi-species animal genetics and human and animal biopharmaceuticals. It has a presence in more than 100 countries, generates a sales revenue of 310 million euros and has 1,800 employees worldwide.